These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 16972725)

  • 1. Survival endpoints and adaptive designs.
    Bauer P
    Biom J; 2006 Aug; 48(4):730-1. PubMed ID: 16972725
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Planning and analyzing adaptive group sequential survival trials.
    Wassmer G
    Biom J; 2006 Aug; 48(4):714-29. PubMed ID: 16972724
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A consultant's perspective on the regulatory hurdles to adaptive trials.
    Mehta CR; Jemiai Y
    Biom J; 2006 Aug; 48(4):604-8; discussion 613-22. PubMed ID: 16972712
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adaptive vs. group sequential self-designing trials.
    Mehrotra DV; Fan X
    Biom J; 2006 Aug; 48(4):710-2; discussion 713. PubMed ID: 16972723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adaptive designs from the viewpoint of an academic biostatistician.
    Schäfer H
    Biom J; 2006 Aug; 48(4):586-90; discussion 613-22. PubMed ID: 16972709
    [TBL] [Abstract][Full Text] [Related]  

  • 6. On efficient two-stage adaptive designs for clinical trials with sample size adjustment.
    Liu Q; Li G; Anderson KM; Lim P
    J Biopharm Stat; 2012; 22(4):617-40. PubMed ID: 22651105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis strategies for adaptive designs with multiple endpoints.
    Chang M; Chow SC
    J Biopharm Stat; 2007; 17(6):1189-200. PubMed ID: 18027225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methodological developments vs. regulatory requirements.
    Bauer P
    Biom J; 2006 Aug; 48(4):609-12; discussion 613-22. PubMed ID: 16972713
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design, data monitoring, and analysis of clinical trials with co-primary endpoints: A review.
    Hamasaki T; Evans SR; Asakura K
    J Biopharm Stat; 2018; 28(1):28-51. PubMed ID: 29083951
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Statistical considerations for testing multiple endpoints in group sequential or adaptive clinical trials.
    Hung HM; Wang SJ; O'Neill R
    J Biopharm Stat; 2007; 17(6):1201-10. PubMed ID: 18027226
    [TBL] [Abstract][Full Text] [Related]  

  • 11. On sample size determination in multi-armed confirmatory adaptive designs.
    Wassmer G
    J Biopharm Stat; 2011 Jul; 21(4):802-17. PubMed ID: 21516570
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Opening the adaptive toolbox.
    Wittes J; Lachenbruch PA
    Biom J; 2006 Aug; 48(4):598-603; discussion 613-22. PubMed ID: 16972711
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plan to be flexible: a commentary on adaptive designs.
    Shih WJ
    Biom J; 2006 Aug; 48(4):656-9; discussion 660-2. PubMed ID: 16972718
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Some aspects of the application of internal pilot studies.
    Lachenbruch PA; Wittes J
    Biom J; 2006 Aug; 48(4):556-7; discussion 558. PubMed ID: 16972705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Repeated confidence intervals for adaptive group sequential trials.
    Mehta CR; Bauer P; Posch M; Brannath W
    Stat Med; 2007 Dec; 26(30):5422-33. PubMed ID: 17918195
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Designing Issues in Confirmatory Adaptive Population Enrichment Trials.
    Wassmer G; Dragalin V
    J Biopharm Stat; 2015; 25(4):651-69. PubMed ID: 24905739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Twenty-five years of confirmatory adaptive designs: opportunities and pitfalls.
    Bauer P; Bretz F; Dragalin V; König F; Wassmer G
    Stat Med; 2016 Feb; 35(3):325-47. PubMed ID: 25778935
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A free gift: an adaptive strategy in a single-arm trial using an exact test through the binomial distribution.
    Wang J
    J Biopharm Stat; 2012; 22(6):1127-36. PubMed ID: 23075012
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adaptive sample size calculations in group sequential trials.
    Lehmacher W; Wassmer G
    Biometrics; 1999 Dec; 55(4):1286-90. PubMed ID: 11315085
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nested combination tests with a time-to-event endpoint using a short-term endpoint for design adaptations.
    Jörgens S; Wassmer G; König F; Posch M
    Pharm Stat; 2019 May; 18(3):329-350. PubMed ID: 30652401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.